Controlled trials and meta-analyses can help resolve disagreements among orthopaedic surgeons. par Chalmers, I, Collins, R, Dickersin, K

Misunderstandings, misperceptions, and mistakes. par Straus, S, Haynes, B, Glasziou, P, Dickersin, K, Guyatt, G

Reply [2] par Glasziou, P, Straus, S, Haynes, B, Dickersin, K, Guyatt, G

Misunderstandings, misperceptions, and mistakes. par Straus, S, Haynes, B, Glasziou, P, Dickersin, K, Guyatt, G

Publication bias in clinical trials due to statistical significance or direction of trial results. par Hopewell, S, Loudon, K, Clarke, M, Oxman, A, Dickersin, K

SPIRIT 2013: new guidance for content of clinical trial protocols. par Chan, A, Tetzlaff, J, Altman, D, Dickersin, K, Moher, D

Network meta-analysis for clinical practice guidelines: a case study on first-line medical therapies for primary open-angle glaucoma par Rouse, B, Cipriani, A, Shi, Q, Coleman, A, Dickersin, K, Li, T

Network meta‐analysis for clinical practice guidelines: a case study on first-line medical therapies for primary open-angle glaucoma par Rouse, B, Cipriani, A, Shi, Q, Coleman, A, Dickersin, K, Li, T

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study par Dechartres, A, Trinquart, L, Atal, I, Moher, D, Dickersin, K, Boutron, I, Perrodeau, E, Altman, D, Ravaud, P

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. par Chan, A, Tetzlaff, J, Gøtzsche, P, Altman, D, Mann, H, Berlin, J, Dickersin, K, Hróbjartsson, A, Schulz, K, Parulekar, W, Krleza-Jeric, K, Laupacis, A, Moher, D

Fisher and Bradford Hill: a discussion par Dickersin, K, Armitage, P, Djulbegovic, B, Chalmers, I, Bodmer, W, Roberts, I, Doll, R, Herxheimer, A, Altman, D, Marks, H, Edwards, M, Vandenbroucke, J, Berridge, V, LeFanu, J

SPIRIT 2013 statement: defining standard protocol items for clinical trials. par Chan, A, Tetzlaff, J, Altman, D, Laupacis, A, Gøtzsche, P, Krleža-Jerić, K, Hróbjartsson, A, Mann, H, Dickersin, K, Berlin, J, Doré, C, Parulekar, W, Summerskill, W, Groves, T, Schulz, K, Sox, H, Rockhold, F, Rennie, D, Moher, D

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement par Moher, D, Liberati, A, Tetzlaff, J, Altman, D, Altman, D, Antes, G, Atkins, D, Barbour, V, Barrowman, N, Berlin, J, Clark, J, Clarke, M, Cook, D, D'Amico, R, Deeks, J, Devereaux, P, Dickersin, K, Egger, M, Ernst, E, Gøtzsche, P, Grimshaw, J, Guyatt, G, Higgins, J, Ioannidis, J, Kleijnen, J

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (Chinese edition) par Moher, D, Liberati, A, Tetzlaff, J, Altman, D, Altman, D, Antes, G, Atkins, D, Barbour, V, Barrowman, N, Berlin, J, Clark, J, Clarke, M, Cook, D, D'Amico, R, Deeks, J, Devereaux, P, Dickersin, K, Egger, M, Ernst, E, Gøtzsche, P, Grimshaw, J, Guyatt, G, Higgins, J, Ioannidis, J, Kleijnen, J

Guidelines for reporting trial protocols and completed trials modified due to the COVID-19 pandemic and other extenuating circumstances: the CONSERVE 2021 statement par Orkin, AM, Gill, PJ, Ghersi, D, Campbell, L, Sugarman, J, Emsley, R, Steg, PG, Weijer, C, Simes, J, Rombey, T, Williams, HC, Wittes, J, Moher, D, Richards, DP, Kasamon, Y, Getz, K, Hopewell, S, Dickersin, K, Wu, T, Ayala, AP, Schulz, KF, Calleja, S, Boutron, I, Ross, JS, Golub, RM, Khan, KM, Mulrow, C, Siegfried, N, Heber, J, Lee, N, Kearney, PR, Wanyenze, RK, Hróbjartsson, A, Williams, R, Bhandari, N, Jüni, P, Chan, A-W